Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

Market Cap	75.93B
Revenue (ttm)	1.72B
Net Income (ttm)	-298.28M
Shares Out	1.27B
EPS (ttm)	-0.22
PE Ratio	n/a
Forward PE	n/a
Dividend	0.32 (0.56%)
Ex-Dividend Date	Jun 3, 2024

Volume	14,373,517
Average Volume	5,348,503
Open	58.52
Previous Close	57.34
Day's Range	58.52 - 61.08
52-Week Range	54.24 - 89.89
Beta	1.27
RSI	46.91
Earnings Date	Aug 28, 2025

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents. The company was founded in 1991 and is headquartered in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 3,790
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603392

Financial Performance

In 2024, SHA:603392's revenue was 2.25 billion, a decrease of -59.25% compared to the previous year's 5.51 billion. Earnings were 106.24 million, a decrease of -91.49%.